Variability of practice in anatomic pathology and its effect on patient outcomes

Seminars in Diagnostic Pathology

Volumn 22, Issue 2, 2005, Pages 177-185

  Raab, Stephen S ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Anatomic pathology; Costs; Error; Practice guidelines; Variation

Indexed keywords

ARTICLE; CLINICAL PRACTICE; DIAGNOSTIC PROCEDURE; EVIDENCE BASED MEDICINE; FINANCIAL MANAGEMENT; GEOGRAPHY; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE UTILIZATION; HUMAN; KAPPA STATISTICS; MEDICAL CARE; MEDICAL LITERATURE; MEDICAL PRACTICE; MEDICAL RESEARCH; OUTCOME ASSESSMENT; PATHOLOGY; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL;

DIAGNOSTIC ERRORS; GUIDELINE ADHERENCE; HEALTH RESOURCES; HUMANS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATHOLOGY, CLINICAL; PATHOLOGY, SURGICAL; PATIENT CARE; PRACTICE GUIDELINES;

EID: 33646110501     PISSN: 07402570     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semdp.2006.01.004     Document Type: Article

References (77)

1. Wennberg J.E., and Gittelsohn A.M. Small area variations in health care delivery. Science 183 (1973) 1102-1108
2. McPherson K., Wennberg J.E., Hovind O.B., et al. Small-area variations in the use of common surgical procedures. an international comparison of New England, England, and Norway. N Engl J Med 307 (1982) 1310-1340
3. Carlisle D.M., Valdez R.B., Shapiro M.F., et al. Geographic variation in rates of selected surgical procedures within Los Angeles County. Health Serv Res 30 (1995) 27-42
4. Leape L.L., Park R.E., Solomon D.H., et al. Relation between surgeons' practice volumes and geographic variation in the rate of carotid endarterectomy. N Engl J Med 321 (1989) 653-657
5. Chassin M.R., Brook R.H., Park R.E., et al. Variations in the use of medical and surgical services by the Medicare population. N Engl J Med 314 (1986) 285-290
6. Chassin M.R., Kosecoff J., Park R.E., et al. Does inappropriate use explain geographic variations in the use of health care services? A study of three procedures. JAMA 258 (1987) 2533-2537
7. Leape L.L., Hilborne L.H., Kahan J.P., et al. Coronary Artery Bypass Graft. A Literature Review and Ratings of Appropriateness and Necessity (1991), Rand, Santa Monica, CA
8. Fisher E.S., Wennberg D.E., Stukel T.A., et al. The implications of regional variations in Medicare spending. Part 1: the content, quality, and accessibility of care. Ann Intern Med 138 (2003) 273-287
9. Birkmeyer N.J., and Weinstein J.N. Medical versus surgical treatment for low back pain. evidence and clinical practice. Eff Clin Prac 2 (1999) 218-227
10. In: Wennberg J., and Cooper M. (Eds). Surgical Treatment of Common Conditions (1998), American Hospital Publishing, Chicago, IL 1998 Dartmouth Atlas of Health Care
11. In: Wennberg J., and Cooper M. (Eds). Practice Variations and the Quality of Surgical Care for Common Conditions (1999), American Hospital Publishing, Chicago,IL 1999 Dartmouth Atlas of Healthcare
12. Birkmeyer J.D., Sharp S.M., Finlayson S.R., et al. Variation profiles of common surgical procedures. Surgery 124 (1998) 917-923
13. Cherkin D.C., Deyo R.A., Loeser J.D., et al. An international comparison of back surgery rates. Spine 19 (1994) 1201-1206
14. Guadagnoli E., Landrum M.B., Peterson E.A., et al. Appropriateness of coronary angiography after myocardial infarction among Medicare beneficiaries. managed care versus fee for service. N Engl J Med 343 (2000) 1460-1466
15. Guadagnoli E., Landrum M.B., Normand S.-L.T., et al. Impact of underuse, overuse, and discretionary use on geographic variation in the use of coronary angiography following acute myocardial infarction. Med Care 39 (2001) 446-458
16. Garg P.P., Landrum M.B., Normand S.L., et al. Understanding individual and small area variation in the underuse of coronary angiography following acute myocardial infarction. Med Care 40 (2002) 614-626
17. Skinner J.S., and Fisher E.S. Regional disparities in Medicare expenditures. an opportunity for reform. Natl Tax J 50 (1997) 413-425
18. Kish M.A. Guide to development of practice guidelines. CID 32 (2001) 851-854
19. In: Field M.J., and Lohr K.N. (Eds). Clinical Practice Guidelines. Directions of a New Program (1990), National Academy Press, Washington DC Committee to Advise the Public Health Service on Clinical Practice Guidelines, Institute of Medicine
20. Agency for Health Care Policy and Research. Using clinical practice guidelines to evaluate quality of care (1995), US Department of Health and Human Services, Washington, DC Agency for Health Care Policy and Research publications 95-0045 (Vol. 1) and 95-0046 (Vol. 2)
21. Shaneyelt T.M., Mayo-Smith M.F., and Rothwangl J. Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. JAMA 281 (1999) 1900-1905
22. Gross P.A. Practice guidelines for infectious diseases. rationale for a work in progress. Clin Infect Dis 26 (1998) 1037-1041
23. Hadorn D.C., McCormick K., and Diohno A. An annotated algorithm approach to clinical guideline development. JAMA 267 (1992) 3311-3314
24. Wright Jr. T.C., Cox J.T., Massad L.S., et al. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 287 (2002) 2120-2129
25. Solomon D., Davey D., Kurman R., et al. The Bethesda System 2001. terminology for reporting the results of cervical cytology. JAMA 287 (2002) 2114-2119
26. Cabana M.D., Rand C.S., Powe N.R., et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 282 (1999) 1458-1465
27. Lomas J., Anderson G.M., Domnick-Pierre K., et al. Do practice guidelines guide practice? The effect of a consensus statement on the practice of physicians. N Engl J Med 321 (1989) 1306-1311
28. Woolf S.H. Practice guidelines: a new reality in medicine, III: impact on patient care. Arch Intern Med 153 (1992) 2646-2655
29. Hayward R.S.A. Clinical practice guidelines on trial. CMAJ 156 (1997) 1725-1727
30. Kanouse D.E., Winkler J.D., Dosecoff J., et al. Changing Medical Practice Through Technology Assessment. An Evaluation of the NIH Consensus Development Program (1989), RAND, Santa Monica, CA
31. Chassin M.R. Practice guidelines. best hope for quality improvement in the 1990s. J Occup Med 32 (1990) 1199-1206
32. Verstappen W.H., van der Weijden T., Sijbrandij J., et al. Effect of a practice-based strategy on test ordering performance of primary care physicians. A randomized trial. JAMA 289 (2003) 2407-2412
33. Wachtel T.J., and O'Sullivan P. Practice guidelines to reduce testing in the hospital. J Gen Intern Med 4 (1990) 335-341
34. Neilson E.G., Johnson K.B., Rosenbloom S.T., et al. The impact of peer management on test-ordering behavior. Ann Intern Med 141 (2004) 196-204
35. Calderon-Margalit R., Mor-Hosef S., Mayer M., et al. An administrative intervention to improve the utilization of laboratory tests within a university hospital. Int J Qual Health Care 17 (2005) 243-248
36. Schreiber G., and McCrory D.C. Performance characteristics of different modalities for diagnosis of suspected lung cancer. summary of published evidence. Chest 123 (2003) 115-128
37. Raab S.S., and Hornberger J. The effect of a patient's risk-taking attitude on the cost effectiveness of testing strategies in the evaluation of pulmonary lesions. Chest 111 (1997) 1583-1590
38. Raab S.S., Raffin T., and Hornberger J. The importance of sputum cytology in the diagnosis of lung cancer. a cost-effectiveness analysis. Chest 112 (1997) 937-945
39. Lacasse Y., Plante J., Martel S., et al. Transthoracic needle biopsy in the diagnosis of solitary pulmonary nodules. a survey of Canadian physicians. J Thorac Cardiovasc Surg 126 (2003) 761-768
40. Grzybicki D.M., Gross T., Geisinger K.R., et al. Estimation of performance and sequential selection of diagnostic tests in patients with lung lesions suspicious for cancer. Arch Pathol Lab Med 126 (2002) 19-27
41. Clary K.M., Silverman J.F., Liu Y., et al. Cytohistologic discrepancies. a means to improve pathology practice and patient outcomes. Am J Clin Pathol 117 (2002) 567-573
42. Raab S.S., Grzybicki D.M., Janosky J.E., et al. Clinical impact and frequency of anatomic pathology errors in cancer diagnosis. Cancer 104 (2005) 2205-2213
43. Nodit L., Balassanian R., Sudilovsky D., et al. Improving the quality of cytology diagnosis. root cause analysis for errors in bronchial washing and brushing specimens. Am J Clin Pathol 124 (2005) 883-893
44. Bennedbaek F.N., Perrild H., and Laszlo H. Diagnosis and treatment of the solitary thyroid nodule. Results of a European survey. Clin Endo 50 (1999) 357-363
45. Condel J.R., Sharbaugh D.T., and Raab S.S. Error-free pathology. applying lean production methods in anatomic pathology. Clin Lab Med 24 (2004) 865-899
46. Ferreiro J.A., Myers J.L., and Bostwick D.G. Accuracy of frozen section diagnosis in surgical pathology. review of a 1-year experience with 24,880 cases at Mayo Clinic Rochester. Mayo Clin Proc 70 (1995) 1222-1223
47. Dahlin D.C. Seventy-five years' experience with frozen sections at the Mayo Clinic. Mayo Clin Proc 55 (1980) 721-723
48. Gal A. The centennial anniversary of the frozen section technique at the Mayo Clinic. Arch Pathol Lab Med 129 (2005) 1532-1535
49. Raab S.S. Improving patient safety by examining pathology errors. Clin Lab Med 24 (2004) 849-863
50. Taylor C.R. Immunomicroscopy. A diagnostic tool for the surgical pathologist (1986), W.B. Saunders Company, " Philadelphia, PA Volume 19 in the series "Major Problems in Pathology
51. Wick M.R., Ritter J.H., and Swanson P.E. The impact of diagnostic immunohistochemistry on patient outcomes. Clin Lab Med 4 (1999) 797-814
52. Raab S.S. Cost analysis for pathologic evaluation of metastatic carcinoma of unknown origin. Path Case Rev 6 (2001) 173-177
53. Raab S.S. Cost effectiveness of immunohistochemistry. Arch Pathol Lab Med 124 (2000) 1185-1191
54. Lortholary A., Abadie-Lacourtoisie S., and Guerin O. Cancers of unknown origin. 311 cases. Bull Cancer 88 (2001) 619-627
55. Gil M., Vadell Nadel C., Fabregat Mayol X., et al. Yield of diagnostic tests in neoplasms of unknown origin. A retrospective study. Rev Clin Esp 186 (1990) 252-258
56. Levine M.N., Drummond M.F., and Labelle R.J. Cost-effectiveness in the diagnosis and treatment of carcinoma of unknown primary origin. CMAJ 133 (1985) 977-987
57. Bugat R., Bataillard A., Lesimple T., et al. Standards, options and recommendations for the management of patient with carcinoma of unknown primary site. Bull Cancer 89 (2002) 869-875
58. Abbruzzese J.L., Abbruzzese M.C., and Lenzi R. Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin. J Clin Oncol 13 (1995) 2094-2103
59. Shapira D.V., and Jarret A.R. The need to consider survival, outcome, and expense when evaluating and treating patients with unknown primary carcinoma. Arch Intern Med 155 (1995) 2050-2054
60. DeYoung B.R., and Wick M.R. Immunohistologic evaluation of metastatic carcinomas of unknown origin. an algorithmic approach. Semin Diag Pathol 17 (2000) 184-193
61. Gamble A.R., Bell J.A., and Pearson A. Use of tumor marker immunohistochemistry to identify primary site of metastatic tumor. Br Med J 306 (1993) 295-298
62. Brown R.W., Campagna L.B., and Dunn J.K. Immunohistochemical identification of tumor markers in metastatic carcinoma. A diagnostic adjunct in the determination of the primary site. Am J Clin Pathol 107 (1997) 12-19
63. Grzybicki D.M., Liu Y.L., Silverman J.F., et al. Utility of diagnostic immunohistochemistry in surgical pathology. Mod Pathol 13 (2000) 218A
64. Matthews W.E., Silverman J.F., Liu Y., et al. Interobserver variability of immunohistochemistry ordering and the need for practice guidelines. Mod Pathol 15 (2002) 333A
65. Llewellyn H. Observer variation, dysplasia grading, and HPV typing. a review. Am J Clin Pathol 114 (2000) S21-S35
66. Landis J.R., and Koch G.G. The measurement of observer agreement for categorical data. Biometrics 33 (1977) 159-174
67. Svanholm H., Starklint H., Gundersen H.J.G., et al. Reproducibility of histomorphologic diagnoses with special reference to the kappa statistic. APMIS 97 (1989) 689-698
68. O'Sullivan J.P., Ismail S.M., Barnes W.S., et al. Interobserver variation in the diagnosis and grading of dyskaryosis in cervical smears. specialist cytopathologists compared with non-specialists. J Clin Pathol 47 (1994) 515-518
69. Jones S., Thomas G.D., and Williamson P. Observer variation in the assessment of adequacy and neoplasia in cervical cytology. Acta Cytol 40 (1996) 226-234
70. Schnitt S.J., Connolly J.L., Tavassoli F.A., et al. Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria. Am J Surg Pathol 16 (1992) 1133-1143
71. Hammond E.H., Compton C.C., Cancer Committee, and College of American Pathologists. Protocols for the examination of tumors of diverse sites. introduction. Arch Pathol Lab Med 123 (1999) 11-13
72. Lawrence W.D. Association of Directors of Anatomic and Surgical Pathology. ADASP recommendations for processing and reporting of lymph node specimens submitted for evaluation of metastatic disease. Virchows Arch 439 (2001) 601-603
73. Hutchins G.M., Berman J.J., Moore G.W., et al., Autopsy Committee of the College of American Pathologists. Practice guidelines for autopsy pathology. autopsy reporting. Arch Pathol Lab Med 123 (1999) 1085-1092
74. Rosai J., Carcangiu M.L., DeLellis R.A., et al., Association of Directors of Anatomic and Surgical Pathology. Recommendations for the reporting of thyroid carcinomas. Hum Pathol 31 (2000) 1199-1201
75. Lawrence W.D., Abdul-Karim F.W., Crum C., et al., Association of Directors of Anatomic and Surgical Pathology. Recommendations for the reporting of surgical specimens containing uterine cervical neoplasms. Hum Pathol 31 (2000) 1194-1198
76. Zarbo R.J., Barnes L., Crissman J.D., et al. Recommendations for the reporting of specimens containing oral cavity and oropharynx neoplasms Association of Directors of Anatomic and Surgical Pathology. Hum Pathol 31 (2000) 1191-1193
77. van der Kwast T.H., Lopes C., Santonja C., et al. Guidelines for processing and reporting of prostatic needle biopsies. J Clin Pathol 56 (2003) 336-340